Jacobio Pharmaceuticals Group Co., Ltd. (01167) released a Next Day Disclosure Return dated October 24, 2025. The announcement reports that 138,000 ordinary shares were repurchased on the Hong Kong Stock Exchange on October 24, bringing treasury shares to 4,010,100. The repurchase price ranged from HKD 7.08 to HKD 7.16 per share, with the total paid amounting to HKD 981,420.

Following this transaction, the number of issued shares excluding treasury shares was reduced to 787,744,980, while total issued shares remained at 791,755,080. According to the announcement, the transaction and subsequent changes align with the repurchase mandate passed on June 10, 2025. The moratorium on new share issuances or sales of treasury shares remains in effect up to November 23, 2025.